EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Vaccine Targets and Antimicrobial Resistance of Streptococcus agalactiae Recovered From Pregnant Women in Brazil

Clarissa Campos Barros iD, Fabíola C Oliveira Kegele iD, Maria Francisca da S N Soares, Douglas Guedes Ferreira iD, Geraldo Renato de Paula iD, Rosana Rocha Barros iD

Tropical Medicine & International Health · 2026-11 · 31 (11) · 1701-1707

DOI: 10.1111/tmi.70212 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tropical Medicine & International Health, online erschienen am 30.07.2026. Verfasst von Clarissa Campos Barros und 5 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil. Hauptthemen laut MEDLINE: Streptococcus agalactiae, Streptococcal Infections, Anti-Bacterial Agents, Pregnancy Complications, Infectious. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The available measure to prevent Streptococcus agalactiae (Group B Streptococcus, GBS ) neonatal infection is intrapartum antibiotic prophylaxis ( IAP ), but it is threatened by bacterial resistance. Therefore, this study aimed to investigate antimicrobial resistance and bacterial targets of vaccines at the most advanced stage of development.

Methods

GBS isolates ( n = 222) recovered from pregnant women between 2019 and 2024 were subjected to capsular polysaccharides and alpha‐like proteins investigation and antimicrobial susceptibility testing. Macrolide and fluoroquinolone resistance determinants and genetic diversity of multidrug‐resistant ( MDR ) isolates were also investigated.

Results

The main capsular types were Ia (78, 35.1%), III (42, 18.9%), V (39, 17.6%) and II (32, 14.4%). Vaccines based on hexavalent capsular polysaccharides and alpha‐like proteins would have 97.3% and 87.5% of predicted efficacy, respectively. Isolates were categorized as not susceptible ( NS ), that is, intermediate and resistant, to levofloxacin (5, 2.3%), clindamycin (11, 5%), erythromycin (58, 26.1%) and tetracycline (171, 77%). Among erythromycin NS isolates, the M phenotype/ mef (A ) gene predominated (47, 81%). All levofloxacin‐resistant isolates showed amino acid substitutions in both GyrA ( S81L ) and ParC ( S79F ). MDR isolates (10, 4.5%) had distinct genetic backgrounds.

Conclusions

Both immunization approaches would be effective in the population. Although the elevated erythromycin resistance rate, one of the highest reported in the country, clindamycin remains an efficient option in IAP. MDR isolates have not resulted from the dissemination of a single clone, but instead showed a polyclonal origin.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcus agalactiaeStreptococcal InfectionsAnti-Bacterial AgentsPregnancy Complications, InfectiousStreptococcal VaccinesDrug Resistance, BacterialHumansFemalePregnancyBrazilMicrobial Sensitivity TestsAdultDrug Resistance, Multiple, Bacterial

Stichwörter der Autor:innen

Streptococcus agalactiaebacterial drug resistancepregnant womenvaccines

Substanzen

Anti-Bacterial AgentsStreptococcal Vaccines

Autor:innen und Institutionen

  • Instituto Biomédico, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
  • Instituto Fernandes Figueira, Fundação Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil.
  • Hospital Universitário Antônio Pedro, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.
  • Faculdade de Farmácia, Universidade Federal Fluminense, Niterói, Rio de Janeiro, Brazil.

ORCID-Profile: Clarissa Campos Barros, Fabíola C Oliveira Kegele, Douglas Guedes Ferreira, Geraldo Renato de Paula, Rosana Rocha Barros

Förderung

  • Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Barros, C. C., Kegele, F. C. O., Soares, M. F. D. S. N., Ferreira, D. G., de Paula, G. R., & Barros, R. R. (2026). Vaccine Targets and Antimicrobial Resistance of Streptococcus agalactiae Recovered From Pregnant Women in Brazil. Tropical Medicine & International Health, 31(11), 1701-1707. https://doi.org/10.1111/tmi.70212

Vancouver

Barros CC, Kegele FCO, Soares MFDSN, Ferreira DG, de Paula GR, Barros RR. Vaccine Targets and Antimicrobial Resistance of Streptococcus agalactiae Recovered From Pregnant Women in Brazil. Tropical Medicine & International Health. 2026;31(11):1701-1707. doi:10.1111/tmi.70212

BibTeX
@article{Barros2026,
  author = {Barros, Clarissa Campos and Kegele, Fabíola C Oliveira and Soares, Maria Francisca da S N and Ferreira, Douglas Guedes and de Paula, Geraldo Renato and Barros, Rosana Rocha},
  title = {Vaccine Targets and Antimicrobial Resistance of Streptococcus agalactiae Recovered From Pregnant Women in Brazil},
  journal = {Tropical Medicine & International Health},
  year = {2026},
  volume = {31},
  number = {11},
  pages = {1701--1707},
  doi = {10.1111/tmi.70212}
}
Kostenlos starten →